Navigation Links
Nephros Reports 2008 Fourth Quarter and Full Year Financial Results
Date:3/31/2009

ed to approximately $1,196,000 in the corresponding period of 2007, an increase of approximately 23%. The Company's net loss was approximately $6,337,000 or $0.17 per basic and diluted common share for the twelve months ended December 31, 2008 compared with approximately $26,356,000 or $1.68 per basic and diluted common share for the corresponding period of 2007. Included in the Company's 2007 net loss is approximately $17,985,000 of non-cash expenses related to the conversion of approximately $18 million principal amount of the Company's notes and accrued interest thereon into shares of Nephros common stock on November 14, 2007. Such non-cash expenses included approximately $13,429,000 for the amortization of beneficial conversion features and approximately $4,556,000 for the amortization of debt discount. The 2007 net loss was reduced by approximately $330,000 in gain from exchange of debt related to the conversion of the Company's notes into shares of Nephros common stock on November 14, 2007.

Loss from operations for the twelve months ended December 31, 2008 was approximately $6,717,000 compared to approximately $7,479,000 in the corresponding period of 2007. The $762,000 reduction in operating loss resulted from an increase of $89,000 in gross profit due to increased revenue and a reduction in selling, general and administrative expenses of $673,000.

As of December 31, 2008, Nephros had cash and cash equivalents of approximately $2,306,000. The Company had approximately $7,000 invested in a certificate of deposit. The Company's independent registered public accountants, Rothstein, Kass & Company, P.C. included a going concern explanatory paragraph in its audit report covering the Company's financial statements for the year ended December 31, 2008. For information regarding the going concern qualification and management's response, please see Nephros' Annual Report on Form 10-K for the year ended December 31, 2008, which
'/>"/>

SOURCE Nephros, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Nephros Strengthens Commercialization Team with Addition of Marketing Executive
2. Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008
3. Nephros Reports 2008 First Quarter Financial Results
4. Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th
5. Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award
6. Nephros Receives Notice of Intention to Delist from AMEX
7. Nephros Common Stock Now Quoted in Pink Sheets
8. Nephros Provides Update on 510k Applications
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
(Date:12/25/2014)... “Every three months the trends for evening ... dress will be one of the hottest styles in the ... Today, the company releases 26 A-line sweetheart evening dresses, and ... , “We are trying our best to help a ... designs. Along with affordable prices, we provide discounted delivery costs ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company ... collection of discounted prom dresses, most of which are ... of the company, the promotion is valid until Jan. ... expand the UK market. , The prom dresses in ... and styles: A-line strapless, empire strapless chiffon, one shoulder, ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, ... discounts on all its wedding dresses. BellasDress has chosen ... more for gift choices for the holiday season. ... can pick suitable wedding gowns here at discount prices. ... shopping experience at its website. , “All ...
(Date:12/25/2014)... 25, 2014 Helen Harris’ RP (Retinitis ... Hills, California after an 8 year battle with breast ... Eve evening in her home in Woodland Hills California ... cancer. , As the founder and ... she pioneered and championed many of today's greatest breakthroughs ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4
... WEDNESDAY, Dec. 15 (HealthDay News) -- Attending Alcoholics Anonymous ... that jailed women and those recently released from jail ... The new study included 223 women at the Rhode ... considered hazardous drinkers, meaning that when they drank, they ...
... (December 15, 2010) Delaying elective surgical procedures after ... increases the risk of infectious complications and raises hospital ... in the December issue of the Journal of ... of infection following surgical procedures continues to be a ...
... International Bionic Engineering Conference 2011 organised by Elsevier, the ... and services, aims to bridge the gap between academic ... rapidly growing and gaining recognition across many disciplines. ... of ideas, Elsevier is calling upon key researchers in ...
... , WEDNESDAY, Dec. 15 (HealthDay News) -- Genes that ... patients with non-small cell lung cancer have been identified ... lung tumors and nearby healthy lung tissue from 30 ... messenger ribonucleic acid (mRNA) associated with 48 known genes ...
... DALLAS Dec. 14, 2010 Researchers at UT ... in cancer cells and normal tissue that predict survival ... cell lung cancer. "Patient responses to cancer treatment ... among tumors," said Dr. David Mangelsdorf, chairman of pharmacology ...
... TORONTO, Ont. 14, 2010Simple changes to how ventilators are ... for transplants, according to new international research involving a ... deteriorate between the time a patient is declared brain ... determine whether they are suitable for transplant. The study ...
Cached Medicine News:Health News:AA May Help Stem Alcohol Abuse in Female Convicts 2Health News:New research finds delaying surgical procedures increases infection risk and health care costs 2Health News:New international conference in bionic engineering 2Health News:Gene information predicts survival time, possible new treatment options for lung-cancer patients 2Health News:Ventilation changes could double number of lungs available for transplant: study 2
(Date:12/24/2014)... -- Echo Therapeutics, Inc. (NASDAQ: ECTE ... permeation, continuous glucose monitoring and associated technologies, today ... been appointed Chief Executive Officer effective December 22, ... of experience in the medical device, pharmaceutical and ... Vice President, Business Development, Otsuka Pharmaceuticals as well as ...
(Date:12/24/2014)... DALLAS , December 24, 2014 /PRNewswire/ ... Research Report on Global Disposable Syringe Industry ... to its online business intelligence library. ... Global Disposable Syringe Industry is a professional ... Syringe market.  For overview analysis, the report ...
(Date:12/24/2014)... , Dec. 23, 2014  Lockton Dunning ... of Lockton Companies, announced the addition of Vice ... will join Lockton Dunning,s Pharmacy Consulting team, Excelsior ... of relevant industry experience to the position.  Most ... Market Sales at Diplomat Specialty Pharmacy, where she ...
Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5Kim Foerster Joins Lockton Companies 2
... Association of Clinical Research Organizations (ACRO), which represents the ... and the public in the U.S. and worldwide, issued ... Implications of the Globalization of Clinical Research" published in ... England Journal of Medicine : The article by ...
... Journal of Medicine employs Quest Diagnostics, blood-based leukemia testingMADISON, ... specimens may detect abnormal white blood cells in patients ... develops, according to research published in the current issue ... Medicine . The finding may lead to a better ...
Cached Medicine Technology:ACRO Comments on NEJM Article on Globalization of Clinical Research 2ACRO Comments on NEJM Article on Globalization of Clinical Research 3Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 2Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 3Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 4
Agglutinating sera for serological identification of E. coli by slide and/or tube agglutination tests. Agglutinating sera are packaged 2 mL / vial....
For presumptive identification of Escherichia coli using enzyme technology. Tests: Indole, MUG...
A direct qualitative enzyme immunoassay for detection of E.coli Shiga Toxin 1 and 2 in fresh or preserved fecal specimens....
Inquire...
Medicine Products: